Deutsche Bank Ag\ Esperion Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

  • $287 Billion
  • Q3 2025

A detailed history of Deutsche Bank Ag\ transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 118,420 shares of ESPR stock, worth $343,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares
118,420
Previous 97,257 21.76%
Holding current value
$343,418
Previous $95,000 229.47%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$0.98 - $2.84 $20,739 - $60,102
21,163 Added 21.76%
118,420 $313,000
Q2 2025

Aug 12, 2025
SELL
$0.73 - $1.41 $20,824 - $40,223
-28,527 Reduced 22.68%
97,257 $95,000
Q1 2025

May 09, 2025
SELL
$1.44 - $2.34 $58,227 - $94,620
-40,436 Reduced 24.33%
125,784 $181,000
Q4 2024

Jun 30, 2025
BUY
$1.61 - $3.83 $65,101 - $154,869
40,436 Added 32.15%
166,220 $365,000
Q4 2024

Feb 14, 2025
SELL
$1.61 - $3.83 $2.24 Million - $5.34 Million
-1,393,852 Reduced 89.35%
166,220 $365,000
Q3 2024

Jun 26, 2025
BUY
$1.61 - $2.73 $2.31 Million - $3.92 Million
1,434,288 Added 1140.28%
1,560,072 $2.57 Million
Q3 2024

Nov 13, 2024
BUY
$1.61 - $2.73 $44,997 - $76,300
27,949 Added 1.82%
1,560,072 $2.57 Million
Q2 2024

Jun 12, 2025
BUY
$1.84 - $3.24 $2.59 Million - $4.56 Million
1,406,339 Added 1118.06%
1,532,123 $3.4 Million
Q2 2024

Aug 14, 2024
BUY
$1.84 - $3.24 $2.82 Million - $4.96 Million
1,532,123 New
1,532,123 $3.4 Million
Q1 2023

May 15, 2023
BUY
$1.46 - $7.3 $22,875 - $114,376
15,668 Added 47.85%
48,413 $76,000
Q4 2022

Feb 13, 2023
BUY
$5.09 - $8.5 $19,988 - $33,379
3,927 Added 13.63%
32,745 $204,000
Q3 2022

Nov 14, 2022
SELL
$5.45 - $8.13 $22,955 - $34,243
-4,212 Reduced 12.75%
28,818 $193,000
Q2 2022

Aug 11, 2022
BUY
$4.77 - $6.67 $12,425 - $17,375
2,605 Added 8.56%
33,030 $210,000
Q1 2022

May 13, 2022
BUY
$3.34 - $5.56 $44,368 - $73,859
13,284 Added 77.5%
30,425 $142,000
Q4 2021

Feb 11, 2022
SELL
$4.81 - $11.92 $9,086 - $22,516
-1,889 Reduced 9.93%
17,141 $86,000
Q3 2021

Nov 04, 2021
SELL
$11.34 - $21.37 $11,169 - $21,049
-985 Reduced 4.92%
19,030 $229,000
Q2 2021

Aug 11, 2021
SELL
$19.4 - $28.71 $16,955 - $25,092
-874 Reduced 4.18%
20,015 $424,000
Q1 2021

May 13, 2021
SELL
$25.12 - $36.89 $39,890 - $58,581
-1,588 Reduced 7.06%
20,889 $585,000
Q4 2020

Feb 16, 2021
BUY
$24.2 - $35.76 $154,444 - $228,220
6,382 Added 39.65%
22,477 $584,000
Q3 2020

Nov 12, 2020
BUY
$31.18 - $52.71 $71,059 - $120,126
2,279 Added 16.5%
16,095 $598,000
Q2 2020

Aug 13, 2020
SELL
$30.04 - $51.31 $4.96 Million - $8.47 Million
-165,119 Reduced 92.28%
13,816 $708,000
Q1 2020

May 14, 2020
SELL
$27.44 - $73.84 $481,325 - $1.3 Million
-17,541 Reduced 8.93%
178,935 $5.64 Million
Q4 2019

Feb 14, 2020
SELL
$35.4 - $59.82 $1.05 Million - $1.78 Million
-29,732 Reduced 13.14%
196,476 $11.7 Million
Q3 2019

Nov 14, 2019
SELL
$34.47 - $47.53 $5.12 Million - $7.05 Million
-148,416 Reduced 39.62%
226,208 $8.29 Million
Q2 2019

Aug 14, 2019
BUY
$40.1 - $52.33 $8.05 Million - $10.5 Million
200,729 Added 115.43%
374,624 $17.4 Million
Q1 2019

May 15, 2019
BUY
$40.11 - $53.57 $6.5 Million - $8.67 Million
161,930 Added 1353.36%
173,895 $6.98 Million
Q4 2018

Feb 14, 2019
SELL
$36.99 - $59.11 $4.79 Million - $7.65 Million
-129,405 Reduced 91.54%
11,965 $550,000
Q3 2018

Dec 21, 2021
BUY
$40.74 - $51.41 $3.89 Million - $4.91 Million
95,451 Added 207.87%
141,370 $6.27 Million
Q3 2018

Nov 14, 2018
SELL
$40.74 - $51.41 $3.19 Million - $4.03 Million
-78,389 Reduced 63.06%
45,919 $2.04 Million
Q2 2018

Apr 21, 2020
BUY
$36.2 - $76.4 $665,175 - $1.4 Million
18,375 Added 17.35%
124,308 $4.87 Million
Q2 2018

Aug 14, 2018
SELL
$36.2 - $76.4 $2.12 Million - $4.47 Million
-58,507 Reduced 35.58%
105,933 $4.15 Million
Q1 2018

Oct 18, 2019
BUY
$65.94 - $80.76 $4.24 Million - $5.19 Million
64,303 Added 64.22%
164,440 $11.9 Million
Q1 2018

May 15, 2018
SELL
$65.94 - $80.76 $4.99 Million - $6.11 Million
-75,650 Reduced 43.04%
100,137 $7.24 Million
Q4 2017

Feb 14, 2018
BUY
$43.47 - $67.43 $2.51 Million - $3.9 Million
57,800 Added 48.99%
175,787 $11.6 Million
Q3 2017

Nov 14, 2017
BUY
$43.8 - $52.77 $5.17 Million - $6.23 Million
117,987
117,987 $5.91 Million

Others Institutions Holding ESPR

# of Institutions
214
Shares Held
114M
Call Options Held
643K
Put Options Held
769K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $193M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email